Sponsor
Vienna, Austria —F-star is leveraging the ability to introduce additional binding sites into antibodies to create fully functional antibody fragments and multi-functional therapeutic candidates.
F-star is leveraging the ability to introduce additional binding sites into antibodies to create fully functional antibody fragments and multi-functional therapeutic candidates.